A detailed history of Bremer Bank National Association transactions in Amgen Inc stock. As of the latest transaction made, Bremer Bank National Association holds 12,529 shares of AMGN stock, worth $3.56 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
12,529
Previous 12,945 3.21%
Holding current value
$3.56 Million
Previous $4.17 Million 21.72%
% of portfolio
0.65%
Previous 0.79%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

SELL
$258.78 - $328.31 $107,652 - $136,576
-416 Reduced 3.21%
12,529 $3.27 Million
Q3 2024

Oct 17, 2024

BUY
$309.38 - $337.38 $105,189 - $114,709
340 Added 2.7%
12,945 $4.17 Million
Q2 2024

Jul 16, 2024

SELL
$262.75 - $319.31 $213,878 - $259,918
-814 Reduced 6.07%
12,605 $3.94 Million
Q1 2024

Apr 17, 2024

SELL
$268.87 - $324.56 $1.1 Million - $1.33 Million
-4,089 Reduced 23.36%
13,419 $3.82 Million
Q4 2023

Jan 11, 2024

BUY
$255.7 - $288.46 $340,336 - $383,940
1,331 Added 8.23%
17,508 $5.04 Million
Q3 2023

Oct 20, 2023

BUY
$218.65 - $271.46 $2.32 Million - $2.87 Million
10,589 Added 189.5%
16,177 $4.35 Million
Q2 2023

Jul 17, 2023

SELL
$214.27 - $253.37 $9,856 - $11,655
-46 Reduced 0.82%
5,588 $1.24 Million
Q1 2023

Apr 13, 2023

SELL
$225.79 - $275.2 $39,287 - $47,884
-174 Reduced 3.0%
5,634 $1.36 Million
Q4 2022

Jan 12, 2023

BUY
$229.03 - $291.01 $1.33 Million - $1.69 Million
5,808 New
5,808 $1.53 Million
Q2 2022

Jul 08, 2022

SELL
$230.71 - $256.74 $19,610 - $21,822
-85 Reduced 7.01%
1,128 $274,000
Q1 2022

Apr 07, 2022

BUY
$219.27 - $242.57 $4,385 - $4,851
20 Added 1.68%
1,213 $294,000
Q4 2021

Jan 10, 2022

SELL
$198.88 - $227.6 $2,386 - $2,731
-12 Reduced 1.0%
1,193 $268,000
Q3 2021

Oct 05, 2021

SELL
$212.27 - $248.7 $36,510 - $42,776
-172 Reduced 12.49%
1,205 $256,000
Q2 2021

Jul 13, 2021

SELL
$233.58 - $259.14 $61,898 - $68,672
-265 Reduced 16.14%
1,377 $335,000
Q1 2021

Apr 07, 2021

SELL
$221.91 - $258.6 $66,794 - $77,838
-301 Reduced 15.49%
1,642 $408,000
Q4 2020

Jan 12, 2021

SELL
$216.38 - $257.67 $7,789 - $9,276
-36 Reduced 1.82%
1,943 $447,000
Q3 2020

Oct 22, 2020

SELL
$234.65 - $260.95 $17,129 - $19,049
-73 Reduced 3.56%
1,979 $503,000
Q2 2020

Jul 28, 2020

SELL
$197.81 - $242.74 $51,430 - $63,112
-260 Reduced 11.25%
2,052 $484,000
Q1 2020

Apr 17, 2020

BUY
$182.24 - $241.7 $24,237 - $32,146
133 Added 6.1%
2,312 $469,000
Q4 2019

Jan 27, 2020

SELL
$189.21 - $243.2 $51,654 - $66,393
-273 Reduced 11.13%
2,179 $526,000
Q3 2019

Oct 03, 2019

SELL
$174.11 - $208.62 $41,612 - $49,860
-239 Reduced 8.88%
2,452 $474,000
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $29,839 - $34,978
-179 Reduced 6.24%
2,691 $496,000
Q1 2019

May 09, 2019

BUY
$180.87 - $203.88 $519,096 - $585,135
2,870 New
2,870 $514,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bremer Bank National Association Portfolio

Follow Bremer Bank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bremer Bank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Bremer Bank National Association with notifications on news.